163 related articles for article (PubMed ID: 8822532)
1. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.
Stockton ME; Rasmussen K
Neuropsychopharmacology; 1996 Feb; 14(2):97-105. PubMed ID: 8822532
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
Stockton ME; Rasmussen K
Psychopharmacology (Berl); 1996 Mar; 124(1-2):50-6. PubMed ID: 8935800
[TBL] [Abstract][Full Text] [Related]
3. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
4. Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs.
Todorova A; Dimpfel W
Eur Neuropsychopharmacol; 1994 Dec; 4(4):491-501. PubMed ID: 7894260
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
6. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
Minabe Y; Emori K; Ashby CR
Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
[TBL] [Abstract][Full Text] [Related]
7. Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats.
Kawashima N; Okuyama S; Omura T; Chaki S; Tomisawa K
Life Sci; 1999; 65(24):2561-71. PubMed ID: 10619364
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons.
Sánchez-Arroyos R; Guitart X
Eur J Pharmacol; 1999 Jul; 378(1):31-7. PubMed ID: 10478562
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
Bowery B; Rothwell LA; Seabrook GR
Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
[TBL] [Abstract][Full Text] [Related]
10. Behavioral characteristics of olanzapine: an atypical neuroleptic.
Fu Y; Zhu ZT; Chen LJ; Yu LP; Jin GZ
Acta Pharmacol Sin; 2000 Apr; 21(4):329-34. PubMed ID: 11324461
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
Wachtel SR; White FJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
[TBL] [Abstract][Full Text] [Related]
12. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat.
Skarsfeldt T
Eur J Pharmacol; 1995 Aug; 281(3):289-94. PubMed ID: 8521912
[TBL] [Abstract][Full Text] [Related]
14. Seroquel: electrophysiological profile of a potential atypical antipsychotic.
Goldstein JM; Litwin LC; Sutton EB; Malick JB
Psychopharmacology (Berl); 1993; 112(2-3):293-8. PubMed ID: 7871033
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.
Timmerman W; Heijmen M; Westerink BH; Bruggeman R; den Boer JA
Psychopharmacology (Berl); 1999 Jun; 144(3):286-94. PubMed ID: 10435397
[TBL] [Abstract][Full Text] [Related]
16. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
Hand TH; Hu XT; Wang RY
Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
[TBL] [Abstract][Full Text] [Related]
18. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.
Rasmussen K; Czachura JF
Neuroreport; 1995 Dec; 7(1):329-32. PubMed ID: 8742482
[TBL] [Abstract][Full Text] [Related]
19. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Shirayama Y; Hashimoto K; Routledge C; Hagan JJ; Ashby CR
Synapse; 2004 Apr; 52(1):20-8. PubMed ID: 14755629
[TBL] [Abstract][Full Text] [Related]
20. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
White FJ; Wang RY
Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
